Ignite Creation Date:
2025-12-26 @ 11:11 PM
Ignite Modification Date:
2026-03-09 @ 9:34 PM
Study NCT ID:
NCT00347412
Status:
COMPLETED
Last Update Posted:
2022-07-25
First Post:
2006-06-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of NOV-002 in Combination With Chemotherapy to Treat Lung Cancer
Sponsor:
Cellectar Biosciences, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
NOV002-C301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None